Eliyahu Sharon Kalif, EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 77,550 shares at $13.52 ($1.0M) on 2024-03-06, disclosed to the SEC on 2024-03-07.
Scheduled sale ($1.0M) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TEVA | SELL | 2026-03-02 | $11.6M | — | Filing → |
| TEVA | SELL | 2025-06-16 | $1.9M | — | Filing → |
| TEVA | SELL | 2025-03-04 | $1.8M | — | Filing → |